Venus Concept shares surge 137.76% premarket after securing short-term debt relief extension and loan amendment with Madryn Health.

Venus Concept (VERO) surged 137.76% in premarket trading following multiple positive developments. The company secured a short-term debt relief extension and amended its loan agreement with Madryn Health, easing liquidity concerns. Additionally, it received 510(k) clearance for the Venus Versa Pro System, a new multi-application platform, signaling regulatory progress and potential revenue growth. Short interest in the stock also dropped by 19.6%, indicating reduced bearish sentiment. These catalysts collectively drove the sharp premarket increase, reflecting improved investor confidence in the firm’s financial stability and product pipeline.